The COVID-19 Pandemic – Insurer Insights Into Challenges, Implications, and Lessons Learned

The novel coronavirus (COVID-19) pandemic has placed enormous pressure on virtually all facets of U.S. society. Much attention has appropriately been placed on the efforts of health care providers to deliver care to those infected with COVID-19. However, less is known about the experiences of the health insurers who reimburse those health care providers for the care they deliver. In a new report supported by the Robert Wood Johnson Foundation, insurance experts at CHIR and the Urban Institute share findings from interviews with executives at 25 health insurance companies on their impressions of the ongoing ramifications of the pandemic and their response to the crisis. Continue reading

April Research Round Up: What We’re Reading

April showers bring May flowers, and plenty of health policy research. This month, CHIR’s Olivia Hoppe reviews studies on the burden of health care costs on families, the affordability of employer-sponsored insurance, the effects of hospital concentration on insurance premiums, and why Medicaid insurers hesitate to sell plans on the Affordable Care Act’s individual market. Continue reading

Stakeholders Respond to the Proposed Health Reimbursement Arrangement Rule. Part I: State Insurance Departments and Marketplaces

In October 2018, the Trump administration proposed rules to expand the use of health reimbursement arrangements (HRAs) by loosening current federal limitations. The administration’s proposal would allow employers to offer employees the tax-advantaged accounts to assist with health care expenses, including premiums, in lieu of employer-sponsored coverage. To understand the potential impact of the proposals, CHIR reviewed comments from various stakeholder groups. For the first blog in our series, Rachel Schwab summarizes comments from state marketplaces and state insurance departments. Continue reading